Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-16 GRIFFITH MELINDA Director Purchase +10,000 $1.00 $10K 30,000
2022-08-15 GRIFFITH MELINDA Director Grant or award +10,000 20,000
2022-08-15 GRIFFITH MELINDA Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2022-06-24 GRIFFITH MELINDA Director Option exercise +10,000 10,000
2022-06-24 GRIFFITH MELINDA Director Option exercise · Restricted Stock Units −10,000 0
2021-06-24 GRIFFITH MELINDA Director Grant or award · Option to Purchase Common Stock +45,000 45,000
2021-06-24 GRIFFITH MELINDA Director Grant or award · Restricted Stock Units +10,000 10,000
2020-06-17 GRIFFITH MELINDA Director Grant or award · Option to purchase common stock +57,000 57,000

Page 1 of 1 · 8 trades